This comprehensive report forecasts the global intravenous solutions market to grow at a CAGR of 5.79% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: The rising popularity of intravenous vitamin C therapy in cancer treatment is one of the major trends in the market. The intravenous vitamin C solution has been observed to have an increased toxicity to cancer cells and improve the patients' quality of life.
According to the report, the growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that is expected to increase the rate of adoption of intravenous solutions among consumers.
Further, the report states that the presence of stringent regulations introduced by governments leads to unnecessary delays and additional costs in manufacturing. This hinders the growth of the vendors and, therefore, the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- B. Braun Melsungen AG
- Claris Lifesciences
- Fresenius Kabi AG
- Hospira Inc
- IV Solutions
- JW Life Science
- Sichuan Kelun Pharmaceutical
- Thai Otsuka Pharmaceutical
- Vifor Pharma
- Widatra Bhakti
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Geographical segmentation
PART 07: Key leading countries
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
PART 16: About the Author
For more information visit http://www.researchandmarkets.com/research/qmt4tr/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-intravenous-solutions-market-cagr-growth-of-579-by-2020---trends-technologies--opportunities-report-2016-2020---key-vendors-iv-solutions-widatra-bhakti-vifor-pharma-300276898.html
SOURCE Research and Markets